Business Today

Infosys Q4 result preview: What investors are expecting

Investors will closely watch Infosys' revenue guidance for next fiscal year and its plans to achieve it. It is expected that it'll provide a revenue growth guidance of 12-14% in constant currency terms, with a buffer for upgrades in preceding months

Sputnik V in India: Dr Reddy's to begin supply of COVID-19 vaccine imported from Russia in May

Drug major Dr Reddy's Laboratories is also going to tap domestically sourced jabs as their production speeds up in India

'Don't want to arrest economy': Sitharaman says govt won't go for lockdowns in a big way

Union Finance Minister Nirmala Sitharaman has said the government will not go for lockdowns as they don't want to arrest the economy

Remdesivir only for hospitalised patients low on oxygen, says Health Ministry

"It is an investigational drug. Its role has been clearly defined in the clinical management protocol. There is no question of the use of Remdesivir in home settings," said NITI Aayog member Dr V K Paul

Panasonic launches semi-rugged ToughBook FZ-55; prices start at Rs 1,49,000

Panasonic believes the new ToughBook will help improve efficiencies for PMETs (Professionals, Managers, Executives and Technicians) across federal/public safety, automotive and utilities (field service and system maintenance)

economic slowdown

From The Magazine

Bhatnagar's Running Shoes

"Some people meditate, I run. It serves the same purpose for me. It calms me down and helps me focus through the day," says Manish Bhatnagar